Clinical Trial Update: Resveratrol in Patients With Non-alcoholic Fatty Liver Disease [NA]

View source ↗

Summary

A completed clinical trial evaluating resveratrol in patients with non-alcoholic fatty liver disease has been updated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• Resveratrol (resveratrol)

Snippet

Sponsor: University of Aarhus | Conditions: Fatty Liver | NA | Status: COMPLETED